Overcoming barriers to biosimilars in inflammatory arthritis
Sign Up to like & getrecommendations! Published in 2019 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-019-0359-7
Abstract: The availability of biosimilars to treat inflammatory diseases has generated concern about changing patients from a bio-originator to its biosimilar to save costs. Studies published in 2019 support the effectiveness and safety of ‘nonmedical switching’… read more here.
Keywords: barriers biosimilars; overcoming barriers; rheumatology; biosimilars inflammatory ... See more keywords
Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2020.1812575
Abstract: ABSTRACT Introduction The use of biological agents in patients with rheumatic diseases has achieved the therapeutic target, i.e., remission or low disease activity. The share of biological agents has been growing with the approval of… read more here.
Keywords: real world; treatment; biosimilars inflammatory; arthritis ... See more keywords